Lipocine Inc. (LPCN)

NCM – Цена в реальном времени. Валюта: USD

2.46

+0.08 (3.36%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

2.55

+0.09 (3.66%)

После закрытия: Jun 26, 2026, 5:57 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Lipocine Inc. (LPCN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Lipocine Inc. (LPCN)

Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154

Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer

Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase

Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026

What's Going On With Lipocine Stock On Monday?

Видео

No Data

Пресс-релизы

Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154

Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026

Search stocks

Lipocine Inc. (LPCN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Lipocine Inc. (LPCN)

Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154

Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer

Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase

Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026

What's Going On With Lipocine Stock On Monday?

Видео

No Data

Пресс-релизы

Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154

Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026